Weavewell

For reference only · Not medical advice

Sources include the CDC, FDA, HIV.gov, Australian STI Management Guidelines, PubMed-indexed research, and other linked references.

Infection

Shigella

Shigella species

Source evidence review: 2026-10-26. Source links are provided for transparency; guidance can change.

Stylized Shigella: short rod-shaped bacteria with a cell wall and no tail-like flagella. Not to scale; not diagnostic.

SEXUALLY TRANSMISSIBLE ENTERIC INFECTION / CARE & TRANSMISSION

Shigella species

Shigella causes a diarrheal illness that can spread when microscopic fecal material reaches the mouth. Sex can provide that route, and so can food, hands and surfaces. Most of what helps is everyday: handwashing, staying hydrated, and antibiotics only when a clinic advises them, because resistance is increasing. [57][58][59]

Transmission risk

Risk by type of contact

Bottom line. Shigella spreads when microscopic fecal material reaches the mouth, including during sexual contact. A condom or dam addresses only part of that pathway; hands and toys matter too.

Type of contact

General

No barrier

Fecal-oral transmission during sex is established; a small inoculum can cause illness, but dose is not a per-act probability.*

  • No numeric estimate
  • Evidence: Low

Infectious stool reaches the mouth; contamination can be microscopic.

Sources 1

With a barrier

Barriers can reduce covered contamination, but no pathogen-specific effectiveness percentage is established.*

  • No numeric estimate
  • Evidence: Low

Hands, toys and uncovered skin remain potential pathways.

Sources 1

Oral

No barrier

Rimming and mouth contact with contaminated genitals, skin or toys are established exposure mechanisms.*

  • No numeric estimate
  • Evidence: Low

Actual fecal-to-mouth transfer; no validated per-rimming-act probability.

The orally exposed partner is at risk; no quantified directional split.

Sources 1, 2

With a barrier

A dam can interrupt covered anus-mouth contact; no clinical Shigella-specific efficacy percentage.*

  • No numeric estimate
  • Evidence: Low

Correct handling, new barrier between contacts; hand contamination can bypass it.

Sources 1

Vaginal

No barrier

Isolated vaginal penetration is not the characteristic mechanism; associated fecal-to-mouth transfer is the concern.*

  • No numeric estimate
  • Risk: Negligible
  • Evidence: Low

No fecal contamination or oral transfer included in the isolated-route statement.

Sources 1

With a barrier

A condom does not address all contaminated hand/toy-to-mouth routes.*

  • No numeric estimate
  • Evidence: Low

No vaginal Shigella-specific condom effect size.

Sources 1

Anal

No barrier

Anal activity can contaminate hands, penis and toys; later transfer to the mouth is the relevant pathway.*

  • No numeric estimate
  • Evidence: Low

Do not interpret this as a measured infection probability from rectal penetration itself.

No validated receptive/insertive probabilities.

Sources 1

With a barrier

Condoms/gloves may reduce contamination but do not eliminate fecal-oral exposure elsewhere.*

  • No numeric estimate
  • Evidence: Low

No Shigella-specific anal barrier efficacy percentage.

Sources 1

Kissing

No barrier

Ordinary kissing is not an established independent route; a mouth contaminated during rimming is a different exposure.*

  • No numeric estimate
  • Risk: Negligible
  • Evidence: Low

No fecal material assumed for ordinary kissing; contaminated-mouth transfer is plausible but unquantified.

Sources 1

With a barrier

Not applicable: condoms and dental dams used for other acts do not protect a separate kissing exposure. No studied kissing-barrier effectiveness estimate.*

  • No numeric estimate
  • Evidence: Low

A separate oral barrier is not a validated kissing intervention; do not render this as a reduced-risk numerical cell.

Sources 1

What changes the risk (3)
  • Diarrhea and continued shedding. LOW for a numeric multiplier: transmission can continue after symptoms improve. CDC advises waiting at least two weeks after diarrhea ends before sex. Sources 1
  • Antibiotic resistance. LOW for a transmissibility effect: extensively drug-resistant strains complicate treatment; resistance prevalence is not a per-act risk multiplier. Sources 3
  • Rimming, hygiene and barriers. LOW for measured efficacy: handwashing, avoiding fecal-to-mouth transfer, cleaning toys and using appropriate barriers are recommended; no validated percentage reduction for each. Sources 1
Condoms and dental dams

No Shigella-specific clinical condom/dental-dam efficacy estimate. Guidance rests on interrupting fecal contamination and transfer, not a measured per-act barrier percentage. Evidence: Low Sources 1

Sources for this risk profile (3)
  1. CDC CDC, 2024. Preventing Shigella Infection. cdc.gov
  2. CDC CDC, 2024. About STI Risk and Oral Sex. cdc.gov
  3. CDC Health Alert Network, 2023. Increase in Extensively Drug-Resistant Shigellosis in the United States. cdc.gov

* How to read these figures. Each is a published estimate under the conditions shown beside it, usually an untreated partner and a single act or partnership. It is not a prediction of your personal risk.

Evidence: High
Several prospective studies or a systematic review broadly agree.
Evidence: Medium
One or two studies, wide uncertainty, or a model.
Evidence: Low
Guideline judgment, case reports, or extrapolation.

Where no risk level is shown, the evidence cannot rank it. That is not the same as low.

Evidence reviewed through 2026-10-27. For reference only; not medical advice.

When to test after a possible exposure

Stool testing is generally triggered by compatible diarrhea or a public-health investigation, not a routine post-sex countdown.

When to be seen sooner. Bloody diarrhea, significant dehydration, fever or persistent illness warrants prompt clinical evaluation.

  • Stool culture or a culture-independent diagnostic test, with culture follow-up when indicated

    • Test if symptoms appear
    • Evidence: Low

    No validated standard asymptomatic post-exposure rule-out day was identified.

    Test suspected shigellosis while clinically indicated; positive molecular testing may need culture for confirmation and resistance assessment.

    Specimens: Stool

    Sources 1

Early negatives, after treatment, and screening limits

An early negative result. A routine negative stool result does not provide a universal guarantee about all future symptoms or every enteric infection.

After treatment. Clearance testing, when required for specific work/setting rules or public-health management, is a separate jurisdiction-specific question.

Screening limits. Routine STI blood or urine panels do not detect Shigella; an enteric test must be specifically indicated.

Kissing and body sites. Rimming, hands, toys or other fecal-to-mouth transfer determine specimen relevance. Ordinary kissing alone does not define a standard stool-testing schedule.

Sources for testing guidance (1)
  1. CDC. Clinical Overview of Shigellosis: testing and diagnosis. 2024. cdc.gov

Treatment

Many uncomplicated cases improve with fluids and rest; severe illness, or someone more vulnerable, may need antibiotics chosen by susceptibility. Antibiotics are best chosen by a clinic, especially after travel or in a resistant outbreak. Medicines that slow the bowel, such as loperamide, are not advised for bloody diarrhea unless a clinician suggests them. [59]

Actions

1. Get significant illness checked. Bloody or persistent diarrhea, fever, dehydration or severe pain are reasons to be seen. Stool testing can identify Shigella; culture and susceptibility testing may follow a molecular result or suspected resistance. [57][59]

2. Pause sexual contact. CDC advises waiting at least two weeks after diarrhea ends before having sex. Keep up careful hand and equipment hygiene afterward, since shedding can continue after you feel better. [58]

3. Tell relevant contacts. Let recent sexual contacts know about a confirmed infection if fecal-oral exposure was possible, and follow public-health advice for household contacts and food work. There is no single lookback period. Antibiotics are not shared with contacts who have no symptoms. [58][59]

SCIENCE & CONTEXT

Shigella / the evidence

History

The dysentery organism later named Shigella was identified in 1897. Antibiotics improved management of severe disease, but resistance has repeatedly changed prescribing. Modern stool molecular tests improve detection; cultures remain valuable because a positive molecular result alone may not identify which antibiotic will work. [59][60]

Impact

Shigella infects the bowel and can cause watery or bloody diarrhea, fever, cramps and a strong urge to pass stool. Staying hydrated matters most. Complications are uncommon, though people with major immune suppression may be at greater risk. Most illness improves within several days; symptoms that are prolonged or severe are worth having reassessed. [57][59]

The relevant exposure is microscopic fecal contamination, not a person's identity or a particular relationship structure. A routine genital STI panel does not rule out an enteric infection, and urine or throat swabs are not substitutes for the appropriate stool test. [57][58][59]

Probability at a glance

Question Evidence-based answer

Per-act sexual probability

Not reliably quantified

Probability with a condom

Not sufficient to describe all fecal-oral routes

When to resume sex

At least 14 days after diarrhea ends

Which test answers the question

Stool testing; culture may guide antibiotics

There is no validated partner-count probability here. The event-specific route, symptoms, local outbreak and timing are more useful than an unsupported population prevalence. [57][58][59]

The practical conclusion: in a group setting, prevention includes hands, equipment, surfaces and the timing of return to sex, not just condoms during intercourse.